Oral 3

Title Poster First Author Abstract or summary Type
On The Horyzon: Moderated Online Social Therapy For Long-Term Recovery In First Episode Psychosis Mario Alvarez-­Jimenez

Background: Early intervention services have demonstrated improved outcomes in first episode psychosis (FEP); however, recent evidence shows that treatment benefits may not be sustainable over time. These findings have resulted in repeated recommendations for the implementation of longer-term treatment programs. An Internet-based intervention specifically designed for FEP patients may provide a cost-effective alternative to prevent loss of treatment benefits from early intervention.

Conference Presentations
The Use Of Metformin In Preventing Obesity And Metabolic Syndrome In Early Psychosis Philip B Ward

The relationship between weight gain and the treatment of first episode psychosis (FEP) with psychotropic medication has been well established, with obesity and metabolic syndrome common sequelae. Such metabolic abnormalities create further disease burden on a population already dealing with mental illness, whose life expectancy is approximately 20 years less than the general population, primarily due to cardiovascular complications.

Conference Presentations
Physical Health Care Of Patients With First-Episode Psychosis: Prevalence Of Dyslipidemia And Weight Gain Aldanie Rho

Psychotropic medication has been associated with increase weight in people experiencing a first episode psychosis (FEP).Thus, the use of metabolic-neutral antipsychotics and regular monitoring have been encouraged. Objective: We aim to present monitoring practices, along with the prevalence of dyslipidemia and weight gain in a sample of 152 patients followed in a specialized early intervention service (PEPP-Montréal, Canada) between 2003 and 2011. Method: All participants completed their baseline metabolic panel.

Conference Presentations
Dont Just Screen, Intervene! Positive Cardiometabolic Health: An Early Intervention Framework For Patients On Psychotropic Medication. Jackie Curtis

The relationship between weight gain and the treatment of first episode psychosis (FEP) with psychotropic medication has been well established, with obesity and metabolic syndrome common sequelae. Such metabolic abnormalities create further disease burden on a population already dealing with mental illness, whose life expectancy is approximately 20 years less than the general population, primarily due to cardiovascular complications.

Conference Presentations
What’s In The Physician’s Toolbox? Medical Management Of Obesity, Diabetes Risk And Cardiovascular Risk Factors In Psychosis. Katherine Samaras - Shiers

People with psychosis have a 20-year shortfall in life expectancy, attributable to cardiovascular disease. People with psychosis also have higher diabetes rates. Mental illness, social isolation and other sociodemographic factors often impair performance in often complex diabetes self-care, with poorer control and ensuing risks of diabetes complications (amputation, renal failure and heart disease). Weight gain and/or obesity associated with antipsychotropic medication-initiation compounds all these risks.

Conference Presentations
How Knowledge About Physical Health Can Be Used In The Development Of An Integrated Health Promotion Intervention Kathryn Greenwood

People with psychosis have a 20% shorter life expectancy, are 5 times more likely to have diabetes and twice as likely to die of cardiovascular disease than the general population. Life style choices and medication impact on physical health which in turn impacts on self esteem, relationships and engagement with interventions. The IMPACT study aims to improve physical health in psychosis. Study 1 is a prospective study of physical, mental and substance use outcomes in 200 people with first episode psychosis assessed at 0, 3, 6 and 12 months.

Conference Presentations